This is a randomized controlled trial examining whether the use of misoprostol or pitocin, in combination with a foley catheter, is more effective at inducing labor in patients with a gravid BMI that is considered obese.
This randomized controlled trial will include patients with a BMI greater than 30 at the time of admission for their induction of labor. Patients will be randomized to either misoprostol or Pitocin to begin induction of labor, alongside the standard foley catheter, and the primary outcome of interest will be length of time from start of induction until delivery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
300
25 mcg vaginally every 6 hours
3-6 mL intravenously every hour
Mount Sinai Hospital
New York, New York, United States
RECRUITINGBronx Care Health System
The Bronx, New York, United States
RECRUITINGTime from induction to delivery
Simple measure calculating time from start of induction until delivery of neonate.
Time frame: start of induction until delivery
Delivery outcome
Simple determination whether patient had a vaginal delivery or delivered by cesarean section.
Time frame: at delivery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.